ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Fatigue"

  • Abstract Number: 1548 • 2014 ACR/ARHP Annual Meeting

    Treatment Effect of Ustekinumab on Fatigue in Patients with Psoriatic Arthritis: Results from a Phase 3 Clinical Trial

    Christopher T. Ritchlin1, Proton Rahman2, Lluís Puig Sanz3, Alice B. Gottlieb4, Arthur Kavanaugh5, Iain B. McInnes6, Shu Li7, Yuhua Wang7, Rita Ganguly8, Alan M. Mendelsohn9 and Chenglong Han8, 1Allergy Immunology & Rheumatology, University of Rochester Medical Center, Rochester, NY, 2Faculty of Medicine, Memorial University of Newfoundland, St. John's, NF, Canada, 3Dermatology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 4Tufts Medical Center, Boston, MA, 5University of California San Diego, La Jolla, CA, 6Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, 7Janssen Research & Development, LLC., Spring House, PA, 8Janssen Global Services, LLC., Malvern, PA, 9Immunology, Janssen Research & Development, LLC., Spring House, PA

    Background/Purpose: To assess the treatment effect of ustekinumab on fatigue using data from PSUMMIT 2. Methods: Adult patients with active psoriatic arthritis (PsA) despite DMARD…
  • Abstract Number: 1382 • 2014 ACR/ARHP Annual Meeting

    The Longitudinal Course of Fatigue in Rheumatoid Arthritis – Results from the Norfolk Arthritis Register

    Katie L Druce1, Gareth T Jones2, Gary J. Macfarlane1, Suzanne M. Verstappen3 and Neil Basu1, 1Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 2Musculoskeletal Research Collaboration (Epidemiology Group),, University of Aberdeen, Aberdeen, United Kingdom, 3Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom

    Background/Purpose: Fatigue is common and burdensome in Rheumatoid Arthritis (RA). Though RA fatigue progression varies significantly between individuals, to date, published analyses have only considered…
  • Abstract Number: 1058 • 2014 ACR/ARHP Annual Meeting

    Levels of Fatigue Are Dependent on Country of Residence in Rheumatoid Arthritis: An Analysis Among 3920 Patients from 17 Countries

    Monika Hifinger1,2, Polina Putrik3,4, Sofia Ramiro5,6, Maxime Dougados7, Laure Gossec8, Andras Keszei9, Ihsane Hmamouchi10 and Annelies Boonen11, 1Rheumatology, University of Maastricht, Maastricht, Netherlands, 2Rheumatology, MUMC, University Hospital Maastricht, Maastricht, Netherlands, 3Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 4Health Promotion, Maastricht University, Maastricht, Netherlands, 5Clinical Immunology and Rheumatology, Amsterdam Rheumatology Center/University of Amsterdam, Amsterdam, Netherlands, 6Rheumatology, Hospital Garcia de Orta, Almada, Portugal, 7Cochin Hospital, Paris Descartes University, Paris, France, 8Rheumatology, Pierre et Marie Curie University, Paris, France, 9Medical Informatics, Uniklinik RWTH Aachen University, Aachen, Germany, 10Biostatistics, Epidemiology LBRCE, Mohamed V Souissi University, Rabat, Morocco, 11Internal Medicine-Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands

    Background/Purpose: For patients with rheumatoid arthritis (RA), fatigue is an important aspect of disease which impacts quality of life. However the complex relationship between fatigue…
  • Abstract Number: 351 • 2014 ACR/ARHP Annual Meeting

    Doctor, Will My Fatigue be Better If I’m in Remission? an Exploratory Analysis of 1284 Rheumatoid Arthritis (RA) Patients Indicates Fatigue Is the Only Aspect of Patient-Perceived Impact to Remain Significant in ACR/EULAR Boolean Remission

    Laure Gossec1,2,3, Bruno Fautrel2,4, John Kirwan1, Andra Balanescu1, Maarten de Wit3, Ben A.C. Dijkmans1, Matthias Englbrecht1, Philippe Gaudin4, Feride Gogus1, Turid Heiberg3, Tore Kristian Kvien1, Emilio Martín-Mola5, Marco Matucci-Cerinic1, Kati Otsa3, Adeline Ruyssen-Witrand4, Tuulikki Sokka-Isler1, Martin Soubrier4 and Maxime Dougados1,4, 1RAID working group for EULAR, Zurich, Switzerland, 2Rheumatology, UPMC GRC08, Paris 06 University, Pitié Salpétrière Hospital, Paris, France, 3PsAID taskforce, EULAR, Zurich, Switzerland, 4COMEDRA trial group, Paris, France, 5Rheumatology, Hospital Universitario La Paz, Madrid, Spain

    Background/Purpose Fatigue is an important issue for patients with rheumatoid arthritis (RA). The ACR/EULAR Boolean definition of remission comprises values 1/10) is a status which…
  • Abstract Number: 126 • 2013 ACR/ARHP Annual Meeting

    Subgrouping Of Rheumatoid Arthritis Patients Based On Pain, Fatigue, Inflammation and Psychosocial Factors

    Yvonne C. Lee1, Michelle A. Frits1, Christine K. Iannaccone1, Michael E. Weinblatt1, Nancy A. Shadick2, David A. Williams3 and Jing Cui1, 1Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 2Rheumatology/Immunology, Brigham and Women's Hospital, Boston, MA, 3Chronic Pain & Fatigue Rsch Ctr, Univ of MI Hlth System-Lobby M, Ann Arbor, MI

    Background/Purpose: Among rheumatoid arthritis (RA) patients, pain may be due to peripheral inflammation or other causes, such as central pain mechanisms. The objective was to…
  • Abstract Number: 135 • 2013 ACR/ARHP Annual Meeting

    Evaluation Of The Quality Of Life and Sleep In Patients With Benign Joint Hypermobility Syndrome

    Ilknur Albayrak1, Halim Yilmaz1, Ekrem Akkurt2, Ali Salli3 and Gulten Karaca4, 1The Department of Physical Medicine and Rehabilitation, Konya Education and Research Hospital, MD, Konya, Turkey, 2The Department of Physical Medicine and Rehabilitation, Konya Education and Research Hospital, Konya, Turkey, MD, Konya, Turkey, 3The Department of Physical Medicine and Rehabilitation, Necmettin Erbakan University, Meram Faculty of Medicine, MD, KONYA, Turkey, 41The Department of Physical Medicine and Rehabilitation, Konya Education and Research Hospital, Konya, Turkey, MD, Konya, Turkey

    Background/Purpose: Traction injuries at tendon or ligament attachment sites, joint instability, low back, back and neck pain can be seen in patients with benign joint…
  • Abstract Number: 2273 • 2013 ACR/ARHP Annual Meeting

    Patient Survey Challenges Conventional Notions Regarding Symptoms and Experiences Of People Living With Rheumatoid Arthritis

    Kelly O'Neill Young1, Cynthia S. Crowson2 and Dana M. Symons1, 1Rheumatoid Patient Foundation, Cocoa, FL, 2Department of Health Sciences Research, Mayo Clinic, Rochester, MN

    Background/Purpose: While rheumatoid arthritis (RA) has been studied for decades, many aspects of the disease are not well understood. Like systemic lupus erythematosus, RA manifests…
  • Abstract Number: 2243 • 2013 ACR/ARHP Annual Meeting

    How Well Do The Three Generic Patient Reported Outcomes Measurement Information System Fatigue Instruments Perform In Rheumatoid Arthritis?

    Susan J. Bartlett1,2, Ana-Maria Orbai3, Trisha Duncan3 and Clifton O. Bingham III3, 1Clinical Epidemiology, McGill University, Montreal, QC, Canada, 2Division of Rheumatology, Johns Hopkins University, Baltimore, MD, 3Rheumatology, Johns Hopkins University, Baltimore, MD

    Background/Purpose: NIH Patient-Reported Outcomes Measurement Information System (PROMIS) has created highly precise and efficient instruments to measure patient-reported outcomes across health domains relevant to chronic…
  • Abstract Number: 751 • 2013 ACR/ARHP Annual Meeting

    Fatigue, Pain, and Functional Disability Among Patients With Vasculitis

    Antoine G. Sreih1,2, Narender Annapureddy3 and Osama Elsallabi4, 1Medicine/Division of Rheumatology, The University of Pennsylvania, Philadelphia, PA, 2Medicine/Rheumatology, Rush University Medical Center, Chicago, IL, 3Rheumatology, Rush University Medical Center, Chicago, IL, 4Medicine, Creighton University, Omaha, NE

    Background/Purpose: Vasculitis is a heterogeneous group of diseases often resulting in severe morbidity affecting patients’ quality of life. These morbidities are generally attributed to disease…
  • Abstract Number: 2689 • 2012 ACR/ARHP Annual Meeting

    Quality of Sleep, Physical Activity and Fatigue in Patients with Rheumatoid Arthritis. A Cross-Sectional Study

    Katrine Loeppenthin1, Bente Appel Esbensen1, Poul Jennum2, Mikkel Østergaard3, Tanja Thomsen1 and Julie Midtgaard4, 1Nursing and Health Science Research Unit, DK-2600 Glostrup, Denmark, 2Danish Centre for Sleep Medicine, Department of Clinical Neurophysiology, DK-2600 Glostrup, Denmark, 3Copenhagen University Hospital Glostrup, Copenhagen, Denmark, 4Health Care Research Centre, Copenhagen, Denmark

    Background/Purpose: Sleep disturbances and fatigue are frequently experienced (40-70 %) in patients with rheumatoid arthritis (RA) and contribute to decreased quality of life and adverse…
  • Abstract Number: 557 • 2012 ACR/ARHP Annual Meeting

    Effect of Certolizumab Pegol On the Multiple Facets of Psoriatic Arthritis As Reported by Patients: 24 Week Patient Reported Outcome Results of a Phase 3 Double Blind Randomized Placebo-Controlled Study

    Dafna D. Gladman1, Roy Fleischmann2, Geoffroy Coteur3, Franz Woltering4 and Philip J. Mease5, 1Centre for Prognosis Studies in The Rheumatic Diseases, Toronto Western Research Institute, University of Toronto, University Health Network, Toronto, ON, Canada, 2University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 3UCB Pharma, Brussels, Belgium, 4UCB Pharma, Monheim, Germany, 5Seattle Rheumatology Associates, Seattle, WA

    Background/Purpose: RAPID-PsA (NCT01087788) reports efficacy and safety of certolizumab pegol (CZP), a PEGylated Fc-free anti-TNF, in psoriatic arthritis (PsA).1 The effect of different imputation methodologies…
  • Abstract Number: 2411 • 2012 ACR/ARHP Annual Meeting

    Obesity Is Associated with Higher Levels of Fatigue in RA

    Patricia P. Katz1, Vladimir Chernitskiy2 and Mary Margaretten2, 1Medicine, University of California San Francisco, San Francisco, CA, 2Rheumatology, University of California, San Francisco, San Francisco, CA

    Background/Purpose: Fatigue is recognized as a major problem for individuals with rheumatoid arthritis (RA), yet the causes of fatigue are not well defined. Obesity appears…
  • Abstract Number: 367 • 2012 ACR/ARHP Annual Meeting

    Improved Fatigue-Related Quality of Life in CAPRA-2, a 12 Week Study of 5-Mg Modified (Delayed) Release Prednisone in Rheumatoid Arthritis

    Rieke Alten1, Amy Grahn2, Patricia Rice3 and Frank Buttgereit4, 1Department of Internal Medicine II, Schlosspark-Klinik, University Medicine, Berlin, Germany, 2Clinical Development, Horizon Pharma, Inc, Deerfield, IL, 3Statistics, CliniRx Research, Naperville, IL, 4Charité - Universitätsmedizin Berlin, Berlin, Germany

    Background/Purpose: Quality of life in rheumatoid arthritis (RA) patients can be improved by reducing the common symptom of fatigue caused by disease related factors such…
  • Abstract Number: 2414 • 2012 ACR/ARHP Annual Meeting

    Multisite Joint Pain and Fatigue:  the Role of Pain Severity and Sleep Problems in Adults with Arthritis

    Mayilee Canizares1 and E.M. Badley2, 1Arthritis Care Research and Evaluation Unit, Division of Health Care and Outcomes Research. Toronto Western Research Institute, Toronto, ON, Canada, 2Division of Health Care and Outcomes Research, Toronto Western Research Institute;Dalla Lana School of Public Health,University of Toronto, Toronto, ON, Canada

    Background/Purpose: Little is known about the severity and determinants of fatigue in adults with arthritis. We hypothesize that the number of joint sites affected  is…
  • Abstract Number: 95 • 2012 ACR/ARHP Annual Meeting

    Smoking Is Associated with Worse and More Widespread Pain, Worse Disease Activity, Function, Fatigue and Health Related Quality of Life in Patients with Axial Spondyloarthritis  –Results From a Population Based Cohort

    Ann B. I. Bremander1, Ingemar F. Petersson2, Emma Haglund3, Stefan Bergman4 and Lennart TH Jacobsson5, 1Department of Exercise Physiology, Biomechanics and Health, Halmstad University School of Business and Engineering, Halmstad, Sweden, 2Lund University, Lund, Sweden, 3Research and Development Centre, Spenshult Hospital for Rheumatic Diseases, Halmstad, Sweden, 4Spenshult Research and Development Center, Halmstad, Sweden, 5Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden

    Background/Purpose: In subjects with early axial Spondyloarthritis (SpA) smoking has recently been associated with earlier onset of disease, worse lesions of the sacroiliac joints and…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology